Skip to main content
. 2018 Apr 6;19(4):1102. doi: 10.3390/ijms19041102

Figure 3.

Figure 3

Induction of SCCA1 and SCCA2 in inflammatory diseases. IL-17/IL-22 and IL-4/IL-13, signature cytokines of type 17 and type 2 inflammation, respectively, can induce SCCA1 and SCCA2 in keratinocytes or airway epithelial cells. IL-17/IL-22 are highly expressed in psoriasis patients, and IL-4/IL-13 are highly expressed in atopic dermatitis (AD) and asthma patients. In some AD patients, IL-17/IL-22 are also expressed.